Legend Biotech Corp (LEGN)
45.18
-1.19
(-2.57%)
USD |
NASDAQ |
May 17, 16:00
45.18
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Cash from Operations (Quarterly): 15.52M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.52M |
| December 31, 2023 | -95.64M |
| September 30, 2023 | -60.85M |
| June 30, 2023 | -97.57M |
| March 31, 2023 | -139.22M |
| December 31, 2022 | -49.74M |
| September 30, 2022 | -72.11M |
| June 30, 2022 | -0.74M |
| March 31, 2022 | -78.69M |
| December 31, 2021 | -69.55M |
| September 30, 2021 | -44.59M |
| Date | Value |
|---|---|
| June 30, 2021 | -57.54M |
| March 31, 2021 | -26.79M |
| December 31, 2020 | -55.95M |
| September 30, 2020 | -64.37M |
| June 30, 2020 | -56.88M |
| March 31, 2020 | -45.80M |
| December 31, 2019 | -59.99M |
| September 30, 2019 | 19.95M |
| June 30, 2019 | -38.77M |
| March 31, 2019 | -4.259M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-139.22M
Minimum
Mar 2023
19.95M
Maximum
Sep 2019
-53.97M
Average
-57.21M
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 3.657B |
| Bristol-Myers Squibb Co | 2.834B |
| 2seventy bio Inc | -41.88M |
| Exelixis Inc | 68.82M |
| Fortrea Holdings Inc | -25.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -396.15M |
| Cash from Financing (Quarterly) | 0.831M |
| Free Cash Flow | -263.24M |
| Free Cash Flow Per Share (Quarterly) | 0.0509 |
| Free Cash Flow to Equity (Quarterly) | 4.205M |
| Free Cash Flow to Firm (Quarterly) | 9.273M |
| Free Cash Flow Yield | -3.23% |